Skip to content

The study is to evaluate tramadol ,dexmedetomedine and clonidine as an adjuvant to levobupivacaine in supraclavicular brachial plexus block

COMPARISON OF TRAMADOL, DEXMEDETOMIDINE AND CLONIDINE AS ADJUVANT TO LEVO BUPIVACAINE FOR SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK FOR UPPER LIMB SURGERY UNDER USG GUIDANCE

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047386
Enrollment
60
Registered
2022-11-17
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: O- Medical and Surgical Health Condition 3: 8- Other Procedures

Interventions

Control Intervention1: Clonidine, Tramadol and dexmedetomedine: 0.5% levobupivacaine with 100mg Tramadol,0.5% levobupivacaine with 1ug /kg body weight Clonidine, 0.5% levobupivacaine with 1ug /kg bod

Sponsors

Jnu hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient who giving informed consent

Exclusion criteria

Exclusion criteria: Patients with previous history or clinical presentation with central or peripheral neurological disease, coagulopathy, infection at the site of injection, patient allergic to any of the study drugs and those unable to co-operate will be excluded from the study.

Design outcomes

Primary

MeasureTime frame
Duration of analgesic Intraoperative hemodynamic monitoringTimepoint: Ramsay scale every 15 min interval

Secondary

MeasureTime frame
Effect of three drugs . â?¢ Hemodynamic responses â?¢ Onset of sensory blockade and motor blockade â?¢ Duration of sensory and motor blockade â?¢ To compare post operative pain levels. â?¢ Complications / side effects if any Timepoint: Every 15 min during operation and afer shifting to ward

Countries

India

Contacts

Public ContactDr Swati Singhal

Jaipur national university institute of medical science and research centre

drswatilokeshsinghal@gmail.com9993613033

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026